View printer-friendly version << Back

Novavax to Host Conference Call to Discuss Second Quarter 2014 Financial Results on August 6, 2014

ROCKVILLE, Md., July 30, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, announced today that it will report its financial results for the second quarter of 2014 on Wednesday, August 6, 2014, after market close.

In addition, management will host a conference call, to discuss the quarterly financial results and provide an update on corporate activities. Conference call details are as follows:

Date: August 6, 2014
Time: 4:30 PM US eastern time
Dial-in number: 1 (877) 212-6076 (domestic) or 1 (707) 287-9331 (international)
Via Web:

Conference call Replay:

Dates: Starting at 6:31pm on August 6, 2014 until midnight October 6, 2014
Dial-in number: 1 (855) 859-2056 (domestic) or 1 (404) 537-3406 (international) 
Passcode: 82216889
Via-Web:, "Investor Info"/"Events"

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biopharmaceutical company creating novel vaccines and vaccine adjuvants to address a broad range of infectious diseases worldwide. Using innovative proprietary recombinant protein nanoparticle vaccine technology, the company produces vaccine candidates to efficiently and effectively respond to both known and newly emergent diseases. Additional information about Novavax is available on the company's website,

CONTACT: Barclay Phillips
         SVP, Chief Financial Officer and Treasurer
         Novavax, Inc.

Novavax logo

Novavax, Inc.

This site uses cookies and similar technologies to provide you with our services, enhance the performance and functionality of our services, and analyze the use of our products and services. By clicking ‘Accept’ you are indicating your consent for us to place these cookies. For more information, please read our Privacy Policy or manage your cookie settings.